论文部分内容阅读
《New Scientist》1984;101(1403):20. 埃塞克斯大学得到英国癌症研究运动的援助,正在研制和试验一组新的抗癌药,在理论上说,这组新抗癌药杀死癌细胞的效力将比目前使用的同类药物大一万亿倍。迄今这些新药仅对白血病和肉瘤细胞的培养物进行过试验,并正在对小鼠初步试用。这些药是按照竞争性酶抑制作用的确定原理发生作用的。如果将一种酶加到含少量这种酶的作用底物和大量模拟这种作用底物的物质
New Scientist 1984;101(1403):20. The University of Essex is receiving assistance from the British Cancer Research Campaign and is developing and testing a new group of anticancer drugs. Theoretically, this new group of anticancer drugs will kill The efficacy of dead cancer cells will be one trillion times greater than the current use of similar drugs. To date, these new drugs have only been tested on cultures of leukemia and sarcoma cells, and preliminary trials are being conducted on mice. These drugs act according to the principle of competitive enzyme inhibition. If an enzyme is added to a substrate containing a small amount of this enzyme and a large amount of material mimicking this substrate